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Edited by Ulf-Ingo Flu¨ggeAbstract ABC transporters from the multidrug resistance-asso-
ciated protein (MRP) subfamily are glutathione S-conjugate
pumps exhibiting a broad substrate speciﬁcity illustrated by
numerous xenobiotics, such as anticancer drugs, herbicides, pes-
ticides and heavy metals. The engineering of MRP transporters
into plants might be interesting either to reduce the quantity of
xenobiotics taken up by the plant in the context of ‘‘safe-food’’
strategies or, conversely, in the development of phytoremediation
strategies in which xenobiotics are sequestered in the vacuolar
compartment. In this report, we obtained Arabidopsis transgenic
plants overexpressing human MRP1. In these plants, expression
of MRP1 did not increase plant resistance to antimony salts
(Sb(III)), a classical glutathione-conjugate substrate of MRP1.
However, the transporter was fully translated in roots and
shoots, and targeted to the plasma membrane. In order to inves-
tigate the functionality of MRP1 in Arabidopsis, mesophyll cell
protoplasts (MCPs) were isolated from transgenic plants and
transport activities were measured by using calcein or Sb(III)
as substrates. Expression of MRP1 at the plasma membrane
was correlated with an increase in the MCPs resistance to
Sb(III) and a limitation of the metalloid content in the protop-
lasts due to an improvement in Sb(III) eﬄux. Moreover, Sb(III)
transport was sensitive to classical inhibitors of the human
MRP1, such as MK571 or glibenclamide. These results demon-
strate that a human ABC transporter can be functionally intro-
duced in Arabidopsis, which might be useful, with the help of
stronger promoters, to reduce the accumulation of xenobiotics
in plants, such as heavy metals from multi-contaminated soils.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Heavy metals in soil pose a serious risk to public safety and
groundwater supplies. Indeed, cadmium, lead, arsenic and
antimony are often found at many contaminated sites. These
contaminants are frequently incorporated into trophic chains
via water, microorganisms and plants. These heavy metals
are usually detoxiﬁed after chelation to glutathion by mem-
brane-located transport proteins such as glutathione-conjugate
transporters (GS-X pumps), a concept originally described by
Ishikawa [1]. GS-X pumps, also known as multidrug resis-
tance-associated proteins (MRPs), constitute a sub-family of
the ATP-binding cassette superfamily of proteins (ABC pro-
teins) implicated in the transport of various compounds, such
as vincristine, daunorubicin, leukotriene-C4, metolachlor-GS,
17b-estradiol-17-(b-D-glucuronide) and antimony [2]. ABC
proteins are ubiquitous and form the largest gene family of
transporters known, with more than 5000 distinct genes ([3];
http://www.pasteur.fr/recherche/unites/pmtg/abc/database.iph-
tml). It is now well established that several yeast (HMT1,
YCF1), Arabidopsis (ATM3, ALS3, PDR12) and mammalian
(MRP1, MRP2) ABC transporters are responsible for the
detoxiﬁcation of heavy metals, such as Cd, Ni, As, Sb, Hg,
Pb, Gd, Al and Pt [4–16]. In Schyzosaccharomyces pombe,
HMT1, the heavy metal transporter 1, is localized at the vac-
uolar membrane and detoxiﬁes Cd-phytochelatins complexes
into the vacuole [11,12]. From a functional point of view,
YCF1, the yeast cadmium factor 1 from Saccharomyces cerevi-
siae, is the homolog of HMT1. YCF1 is a GS-X pump that
confers to this organism resistance to Cd, As, Sb, Hg and Pb
[4,6,7,17–20]. YCF1 is located at the vacuolar membrane and
transports glutathione-S-chelates, such as Cd(GS)2, Sb(GS)3
or As(GS)3, from the cytosol to the vacuole [4,17–20]. YCF1
and MRP1 are closely related, not only in terms of sequence
(43% identity, 63% similarity), but also in function [21].
MRP1 can restore Cd resistance in Dycf1 yeast strains [22].
However, to our knowledge, a direct demonstration that
MRP1 is a Cd(GS)2 transporter has not been obtained yet.
Besides Cd(II), MRP1 is involved in the cellular detoxiﬁcation
of diﬀerent heavy metals in humans, such as Hg(II), As(III),
As(V), Sb(III) and Sb(V) [5,9,10,23]. For instance, Sb(III),
forming tri-glutathione chelates, is very eﬃciently detoxiﬁed
by MRP1. Thanks to this property, an antimony-selected cell
line overexpressing MRP1 has been generated that is 35-fold
more resistant to Sb(III) than the parental counterpart [9].blished by Elsevier B.V. All rights reserved.
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plants could serve two opposite objectives. First, overexpres-
sion of eﬄuxing plasma membrane MRP pumps could reduce
the quantity of xenobiotics in the plant, thus lowering their en-
try into trophic chains (’’safe-food’’ strategies). Conversely,
overexpression of vacuolar ABC transporters could induce
accumulation of xenobiotics into the vacuole, thus participat-
ing in the development of phytoremediation strategies. This
second strategy seems promising since overexpression of
YCF1 in Arabidopsis thaliana confers to this model plant en-
hanced tolerance and accumulation properties for Pb and Cd
[7]. In both strategies, the soil composition (pH, percentage
of humic fractions, content of metals, etc.) is a major parame-
ter determining the availability of the metals for the plant;
thus, the success of the approach. Moreover, soils are usually
multi-contaminated (for instance, the association of Sb and
Pb), and it is thus relevant to evaluate the contribution of
diﬀerent ABC transporters that present diﬀerent substrate
speciﬁcities. Since MRP1 is a very eﬃcient transporter impli-
cated in the excretion of numerous substances toxic for
humans, its introduction in plant cells could oﬀer new potenti-
alities limiting the penetration of xenobiotics, notably heavy
metals, in human foods. To test this hypothesis, we investi-
gated in this study the consequence of the introduction of
the human MRP1 in the context of plants naturally expressing
various AtMRPs (more than 14 genes in the Arabidopsis
genome; cf. [24,25]). Since MRP1 is an eﬀective transporter
of antimony in mammalian cells [5,9,10], our study has been
focused on this substrate.2. Materials and methods
2.1. Plant material and growth conditions
Arabidopsis thaliana ecotype Wassilewskija plants were grown in
sand as previously described [26]. During heavy metal and anticancer
drug treatments, transgenic (T3 generation) and wild-type plants were
maintained in a growth chamber with a short-day photoperiod of 8-h
light and 16-h darkness at 21 C/18 C, respectively, at a light intensity
of 100 lmol m2 s1. Sterile seeds were plated onto half-strength
Murashige and Skoog medium, pH 5.6, and 0.7 g l1 agar. After
1 day at 4C, seeds were germinated in a vertical orientation for 5 days
in a short-day growth chamber. The plantlets were then transferred to
half-strength Murashige and Skoog medium in absence or in presence
of various xenobiotics (As(III), As(IV), Sb(III), Cd(II), doxorubicin,
vinblastine) and were grown for an additional 9 day period, following
which root lengths were measured. Typically, the assays involved 10
seedlings per genotype and per growth condition.
2.2. Plant expression constructs, transformation and selection
In order to localize HsMRP1, the C-terminal part of MRP1 was
epitope-tagged with GFP. The plasmids pEGFP-N2 (from BD Biosci-
ences) and pFast-Bac1-MRP1-His were used to generate the HsMRP1-
EGFP-N2 fusion by the splicing by overlap extension technique [27].
The oligonucleotides and conditions used for the fusion are given in
supplementary data. The HsMRP1-EGFP-N2 fusion sequence was
subcloned into the pCR–XL-TOPO vector (Invitrogen) and se-
quenced. After digestion with EcoRV, the CaMV35S cassette was sub-
cloned into the EcoRV/StuI sites of the pGreen0179 binary vector,
giving the pVF90 clone [28]. The enhanced green ﬂuorescent protein
(EGFP) was cloned into the EcoRI site of the pVF90 described above.
The HsMRP1-EGFP-N2 sequence was extracted by XbaI/SacI diges-
tion and cloned at the same sites in the pVF90 vector. Following intro-
duction of the constructs or of the empty vector with the pSOUP [29]
in Agrobacterium tumefaciens AGL1 by electroporation, the Arabidop-
sis plants were transformed by the ﬂoral dip method [30]. The trans-
formed plants were selected on solid medium supplemented with
hygromycin B (30 mg l1).2.3. Northern and Western-blot analysis
Total RNA was isolated from leaves of A. thaliana using TRIzol
(Life Technologies). Northern blot analyses were carried out on T1
transformant plant using an EGFP probe labelled with DIG-dUTP
as described [31]. RNA loading was checked with ethidium bromide.
Total protein or microsomes extracted from shoots or mesophyll cell
protoplasts (MCPs) were denaturated and subjected to SDS–PAGE
electrophoresis. After transfer onto nylon membrane, proteins were de-
tected with an anti-GFP antibody (Monoclonal antibody JL-8, BD
Biosciences).
2.4. Localization of MRP1-EGFP in plants and transport experiments
MCPs from A. thaliana were isolated from 5-week-old plant leaves
by enzymatic digestion (1-h at 30 C) in 8 mM CaCl2, 0.5 M Mannitol,
5 mM MES, 1% Cellulase R10, 0.25% macerozyme, 1 mM KH2PO4,
0.5 mM ascorbate, 0.1% PVP40, pH 5.6 KOH. Obtention of MCPs
was checked under the microscope and cells were washed and resus-
pended in the MC buﬀer (0.5 M sorbitol, 1 mM CaCl2, 10 mM
MES, pH 5.6 KOH). Root cell protoplasts (RCPs) were obtained by
using the same protocol, except that Cellulase R10 was increased to
1.5%, macerozyme was substituted by 0.03% pectolyase Y-23 (enzy-
matic digestion during 3-h at 27 C, in darkness). Expression of the
EGFP was monitored using an epiﬂuorescence microscope (Nikon,
Optiphot 2) ﬁtted with a CCD camera (AxioCam, Zeiss, Gottingen,
Germany) to capture pictures. EGFP-N2 has an excitation peak at
488 nm with an emission peak at 507 nm.
For heavy metal transport experiments or cell integrity tests, MCPs
diluted in the MC buﬀer were exposed for 1-h to appropriate
Sb(III)Cl3 concentrations. To determine the metal content, cells were
gently washed in MC buﬀer, pelleted, dried for 48-h at 50 C and min-
eralized by 200 ll of 70% nitric acid before analysis by ICP-OES (Vista
MPX, Varian). To evaluate cell integrity, the number of intact MCPs
was determined before and after treatment by counting under the
microscope with a Malassez cell. Similar results were obtained in con-
trol experiments when FDA was used as a marker of cell viability. In
all cases, MCPs exhibiting a shrinking or partial disruption of the chlo-
roplast envelopes were not taken into account. Transport of 0.5 lM
calcein-AM (Molecular probes) by MCPs was determined by a 1-h
incubation at 30 C in MC buﬀer. MCPs were centrifuged and quanti-
ﬁcation of the ﬂuorescent dye released in the supernatant was per-
formed as previously described [9]. Detection of the calcein was
performed with a microplate ﬂuorescence reader (FLX-800, Bio-Tek
Instruments Inc.), using a 485 ± 20 nm excitation ﬁlter and a
528 ± 20 nm emission ﬁlter. In order to measure the Sb(III) eﬄux
(Fig. 5C), cells were ﬁrst loaded with 200 lMSb(III)Cl3 in the MC buf-
fer for 1-h (at 4 C in order to limit the eﬄux), washed and then incu-
bated in a Sb(III)-free medium at 30 C. The metal content was
determined by ICP-OES as described above. Eﬄuxes were blocked
either with MK571 (kindly provided by Dr. Ford-Hutchinson,
Merck-Frosst Inc., Canada), a speciﬁc inhibitor of MRP1 known to
speciﬁcally reverse MRP1-mediated anticancer drug resistance [32],
or by glibenclamide (from Sigma).3. Results and discussion
3.1. Generation of MRP1-EGFP over-expressing plants
A. thaliana ecotype Wassilewskija plants were engineered to
overexpress the exogenous human HsMRP1 under the control
of the CaMV 35S strong constitutive promoter in a modiﬁed
pGREEN vector. EGFP was fused at the C-terminal part of
HsMRP1 to localize its expression in the transgenic plants.
As a result, 26 independent transgenic Arabidopsis lines desig-
nated 35S-MRP1-EGFP#1 to 35S-MRP1-EGFP#26 were
produced. As a control, 9 independent lines, 35S-EGFP#1 to
35S-EGFP#9, over-expressing EGFP alone under the control
of a CaMV 35S promoter were also generated. T2 lines were
obtained from individual T1 plants by self-fertilization. Trans-
genic lines that displayed 3:1 segregation for hygromycin resis-
tance in the T2 generation and that were 100% hygromycin
resistant in the T3 generation were selected for further analy-
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to select plants over-expressing Hs MRP1 (Fig. 1). Among
them, two lines over-expressing Hs MRP1::EGFP (35S-
MRP1-EGFP#4 and 35S-MRP1-EGFP#22) and one line
over-expressing EGFP (35S-EGFP#6) were selected for their
capacity to overexpress the corresponding mRNA. Transgenic
plants T1, T2 and T3 did not show any noticeable diﬀerence
compared to wild-type (WT) plants grown under normal con-
ditions (data not shown). Diﬀerent control plants, including
transformation controls and wild-type plants, were used as ref-
erences. In the following, transgenic lines 35S-EGFP#6, 35S-
MRP1-EGFP#4 and 35S-MRP1-EGFP#22 were renamed as
GFP6.9, MRP4.18 and MRP22.14, respectively.
3.2. MRP1-EGFP is addressed to the plasma membrane but not
to the vacuolar membrane of transgenic plants
In order to investigate the expression of MRP1-EGFP in
transgenic plants, Western-blot analyses were carried out.113 4 5 6 73 4 52 5
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Fig. 1. RNA gel blot analysis of wild-type (WT), transgenic 35S, 35S-EGFP
probe an RNA gel blot containing RNA (5 lg) prepared from the leaves of
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Fig. 2. The MRP1-EGFP fusion protein is fully translated in A. thaliana. Im
cell protoplasts (MCPs, B) extracted from wild type (WT), GFP6.9, MRP4.Total protein from either root cell protoplasts (RCPs,
Fig. 2A) or mesophyll cell protoplasts (MCPs, Fig. 2B) were
extracted from all transgenic lines. EGFP alone was detected
at an apparent molecular mass of 31-kDa (expected at 27-
kDa) in the GFP6.9 transgenic line (Fig. 2A, GFP6.9 lane).
As illustrated in Fig. 2, in all cell-types tested, anti-GFP anti-
bodies revealed a polypeptide with an apparent molecular
mass close to 200-kDa in both MRP1-EGFP transgenic lines
(theoretical molecular mass 198 kDa). No obvious cleavage
of the GFP was observed whatever the MRP1-EGFP-express-
ing tissue tested. These results indicate that MRP1-EGFP is
fully translated by the plant cellular machinery in the root,
as well as the shoot, compartment.
In a second step, the sub-cellular localization of MRP1-
EGFP in transgenic plants was investigated in MCPs by ﬂuo-
rescence microscopy. Fig. 3A and B shows a clear plasma
membrane localization of the transporter in MCPs (white ar-
rows) as well as in epidermal cells (black arrows). In order14 15 21 22 23 26
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uolar membrane, the MC buﬀer was gently diluted in order to
induce a slow turgescence of the protoplasts. Vacuoles were
obtained from bursting MCPs. As illustrated in Fig. 3C and
D, no GFP ﬂuorescence was observed at the vacuolar mem-
brane, either in isolated vacuoles (black arrows) or in vacuoles
still in release from the MCPs (white arrows). Similar results
were obtained with both MRP4.18 and MRP22.14 transgenic
lines. Detection by Western-blots of MRP1-EGFP in roots
(Fig. 2A) was conﬁrmed by the analysis of the EGFP epiﬂuo-
rescence in the primary root apex (Fig. 3E–H). For these
experiments, a ﬁrst capture of the ﬂuorescent signal from the
GFP6.9 line was obtained (Fig. 3F) and the exposure time of
the CDD camera used for this image was then kept constant
for all subsequent acquisitions. As a result, no auto-ﬂuores-
cence was observed in wild-type plants (Fig. 3E), whereas a
clear GFP ﬂuorescent emission was present in MRP1-EGFP
lines (Fig. 3G–H). Altogether, these results demonstrate that
the human MRP1 is expressed throughout A. thaliana trans-
genic plants and localized at the plasma membrane.
3.3. Plant tolerance to heavy metals and anticancer drugs
In humans, MRP1 confers an ATP-dependent resistance to
several natural products (e.g., anthracyclines or Vinca alka-A B
100 µm 100 µm
E F G
WT GFP6.9
Fig. 3. The MRP1-EGFP fusion protein is expressed at the plasma mem
determined by ﬂuorescence microscopy in MCPs (A–D). MCPs extracted from
corresponding cells, chloroplasts were revealed by red ﬂuorescence emission
plasma membrane (B), either in MCPs (white arrows) or in epidermal cells (bl
buﬀer was applied, a swelling of the cells was initiated leading to the progres
(black arrows). When these vacuoles were observed by ﬂuorescence microsco
collected from the diﬀerent plant genotypes obtained by ﬂuorescence microsc
of the ﬂuorescence signal with GFP6.9 plants. Arrows in the bright ﬁeld imag
interface between the primary root and the nutrient solid medium.loids), folic acid analogues, arsenic and antimonial oxyanions,
but is also a primary active transporter of glutathione-, glucu-
ronate- and sulphate-conjugated organic anions [2]. In order to
evaluate the functional activity of MRP1-EGFP in Arabidop-
sis, MRP4.18 and MRP22.14 transgenic plantlets were grown
in the presence of various heavy metals (1–10 lM As(III),
1–300 lM As(V), 1–40 lM Sb(III) or 1–100 lM Cd(II)). In
all cases, as illustrated for 20 lM Sb(III) in Fig. 4, MRP4.18
and MRP22.14 transgenic plants were indistinguishable
from wild-type plants, plants overexpressing the empty vector
or plants overexpressing GFP alone (GFP6.9). Similar
results were obtained when diﬀerent culture mediums (half-
strength Murashige and Skoog or Hoagland medium, with/
without 1% sugar) and diﬀerent growth temperatures (22
or 30 C) were used. Moreover, no diﬀerence was observed
between Sb(III), Cd(II) or As(III) accumulation in plants, as
determined by ICP-OES analysis (data not shown). It is worth
noting that the eﬀects of cytotoxic drugs, such as doxorubicin
or vinblastine (1–100 lM), were also investigated. However, a
degradation of these compounds was observed as a decolor-
ation of the plant medium within a few hours in the phytotron.
This photosensitivity of the molecules has also been recently
observed [33] and prevents further investigation of anticancer
drugs under these plant culture conditions.C
D
100 µm 100 µm
H
MRP4.18 MRP22.14
brane in A. thaliana transgenic lines. MRP1-EGFP localization was
the MRP22.14 transgenic line were observed in bright light (A). In the
, whereas MRP1-EGFP was detected by the green ﬂuorescence at the
ack arrows). As observed in bright light (C), when a dilution of the MC
sive bursting of the protoplasts (white arrows), leaving intact vacuoles
py, no GFP was detected (D). (E–H). Images of the primary root apex
opy (upper panel) or in bright light (lower panel) after standardization
es highlight the diﬀraction of the light surrounding the root tissue at the
WT MRP4.18
Control
20 µM Sb(III)
Fig. 4. In intact plants, MRP1-EGFP over-expression does not
aﬀect root growth on Sb(III)-contaminated medium. Seeds from the
MRP4.18 line were sown on half-strength MS media, grown for 5 days
and then transferred to media with or without 20 lM Sb(III) for 9
additional days (lower and upper panels, respectively). Similar results
were observed with the MRP22.14 transgenic line (data not shown).
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calcein and antimony salts
Our results suggest either that MRP1-EGFP is not func-
tional in plants or that the cellular eﬄux of heavy metals by
MRP1-EGFP is insuﬃcient to confer an increased tolerance
to antimony salts to the transgenic plants. To answer this ques-
tion, MCPs were isolated and the transport activity supported
by MRP1-EGFP was directly measured. In a ﬁrst step, we
took advantage of the fact that MRP1 activity can be probed
using a calcein assay [9,34]. As shown in Fig. 5A, the cellular
eﬄux of the ﬂuorescent dye was strongly increased in
MRP1-EGFP-overexpressing cells in comparison to that ob-
served in wild type or EGFP-expressing cells. In a second step,
we investigated the ability of MRP1-EGFP to transport
Sb(III). Indeed, in mammals, MRP1-overexpressing GLC4/
Sb30 cells have been demonstrated to be 35-fold more resistant
to antimonial salts [9]. For this purpose, the sensitivity of
MCPs to the cytotoxic eﬀects of Sb(III) was determined by
counting intact cells. Under control conditions, after 1-h, al-
most 100% of the cells were intact, whatever the genotype.
When MCPs were exposed to 200 lM Sb(III) for 1-h, less than
50% of the wild type cells survived, whereas more than 70% of
MCPs isolated from the two transgenic lines overexpressing
MRP1 survived (Fig. 5B). A concomitant application of
Sb(III) with either glibenclamide, an inhibitor of MRP1 [35]
and a useful tool to trap anionic ﬂuorescent dyes in the cytosol
of plant cells [36], or MK571, a potent inhibitor of MRP1
known to speciﬁcally reverse MRP1-mediated anticancer drug
resistance [32], markedly diminished the resistance of MRP1-
overexpressing cells. In contrast, these compounds did not af-
fect the sensitivity to antimony of wild type cells, indicating
that endogenous AtMRPs were either not involved in the large
Sb(III) eﬄux observed or, alternatively, that these plant pro-
teins are insensitive to MK571 and glibenclamide. In a third
step, the kinetics of Sb(III) eﬄux were measured (Fig. 5C).
After 10-min, 75% of the metalloid was eﬄuxed by control
cells, a value reaching 95% in MRP1-EGFP-overexpressingcells. Compared to MRP1 expressed in GLC4/Sb30 cells [9],
these plant protoplasts exhibit a rapid eﬄux of antimony. Fi-
nally, the direct contribution of MRP1-EGFP in the cellular
transport of Sb(III) was investigated by the measurement of
the cellular accumulation of antimony in the diﬀerent trans-
genic lines. Antimony content in MCPs, which reached a mean
of 8.5 lg per mg of protein within 1-h in wild type and GFP
transgenic lines, was reduced by 45% to reach a mean of
4.6 lg per mg of protein in MRP1-EGFP-overexpressing lines
(Fig. 5D). The co-application of Sb(III) with either glibencla-
mide or MK571 markedly enhanced the antimony retention
in MCPs from both MRP1-EGFP transgenic lines.
In humans, it has already been demonstrated that a C-termi-
nal GFP fusion of the human MRP1 keeps its intracellular
localization and is still functional [37]. In the present study,
the fusion protein was correctly localized and active in detox-
ifying calcein or antimony salts. The fact that transgenic plants
did not exhibit a resistance phenotype to MRP1 substrates was
unexpected but could be explained by the following reasons.
First, in plant cells, the vacuole is the main organelle for the
sequestration of toxic compounds once they have penetrated
the cytoplasm. As we have seen, MRP1 is not localized to
the vacuolar membrane in A. thaliana transgenic plants. In
contrast, when YCF1 fused to GFP (either at the N- or C-ter-
minal part) was overexpressed in Arabidopsis, both vacuolar
and plasma membrane localizations were observed. This was
accompanied by an increased Cd inﬂux into the vacuole mea-
sured during uptake experiments, and explains why transgenic
plants were more tolerant to Cd [7]. Such a critical importance
of vacuolar sequestration of toxic compounds in plant cells
may explain why the unique presence of MRP1 at the plasma
membrane is insuﬃcient to confer Sb(III) tolerance in planta.
Interestingly, as published in a very recent work [33], MRP1
expression in tobacco plants under a 35S promoter equipped
with a tandem enhancer sequence El2 resulted in a vacuolar
membrane localization of the protein. These plants were
shown to be more tolerant to Cd, although they did not accu-
mulate more metal. This underlines the uncertainties inherent
to heterologous expression concerning protein localization
depending on the host or the vector used. It is possible that
in our study using Arabidopsis and expression of MRP1-
EGFP under the control of a single 35S promoter, the level
of active protein is insuﬃcient to confer a whole plant pheno-
type. This is supported by the observation that the activity of
YCF1 in transgenic plants was strongly improved when four
copies of the CaMV 35S enhancer were inserted into the plant
transformation vector [7]. Moreover, in our study, a high
Sb(III) eﬄux activity carried out by endogenous transporters
was already observed in control plants (Fig. 5C), diminishing
the beneﬁt of MRP1 expression. A ﬁnal reason that could ex-
plain the absence of a resistance phenotype might be due to
Sb(III) speciation. Antimony–(GS)3 complexes eﬄuxed by
MRP1 from the cytosol could be dissociated in the more acidic
apoplastic medium to release Sb(III). In such case, Sb(III)
could re-enter into the cell for a new cycle without any beneﬁt
for the plant.
In conclusion, these results demonstrate that a human ABC
transporter can be functionally introduced into A. thaliana and
is addressed to the plasma membrane, which corresponds to its
localization in human cells. The transporter is functional in
transferring calcein and Sb(III) and is still sensitive to its clas-
sical modulators, MK571 and glibenclamide. It is likely that
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Fig. 5. The MRP1-EGFP fusion protein drives the eﬄux of calcein and Sb(III) in MCPs of A. thaliana transgenic lines. (A) MRP1-EGFP
participates in the cellular eﬄux of calcein from A. thaliana transgenic MCPs. MCPs were incubated with 0.5 lM calcein-AM for 1-h at 30 C. The
calcein eﬄux from MCPs isolated from wild type plants (WT), GFP6.9 plants, MRP4.18 plants and MRP22.14 plants was quantiﬁed by
spectroﬂuorimetry. (B) Cells overexpressing MRP1-EGFP exhibited a better tolerance to antimony salts compared to wild type cells. MCPs isolated
from the diﬀerent transgenic lines were incubated with 200 lM Sb(III)Cl3 for 1-h at 30 C in the presence or absence of 10 lM glibenclamide or
50 lMMK571. Under each condition, the number of cells was calculated as the ratio of the number of intact MCPs in the presence vs. the absence of
treatment. One hundred percent corresponds to 1 · 105 MCPs per ml. (C) Sb(III) eﬄux was enhanced in MRP1-EGFP-overexpressing cells. Cells
were ﬁrst loaded with 200 lM Sb(III)Cl3 for 1-h (at 4 C), washed and then incubated in a Sb(III)-free medium. Intracellular antimony content was
measured at diﬀerent times and expressed as a percentage of the initial intracellular Sb(III) content. (D) Antimony accumulation was reduced in
MCPs isolated from MRP4.18 and MRP22.14 plants. Experimental conditions were similar to those described in (B). The Sb content measured by
ICP-OES was expressed on a protein basis. (A–D) Each bar is the mean ± S.E. of three independent experiments.
6896 L. Gayet et al. / FEBS Letters 580 (2006) 6891–6897the level of expression of the protein is insuﬃcient to confer to
transgenic plants a strong resistance phenotype to xenobiotics,
but potentially, this goal could be achieved by using stronger
promoters. On the other hand, stable A. thaliana cell cul-
tures over-expressing human MRP1, where endogenous plants
MRPs either have or have not been knocked out, could oﬀer a
novel tool to screen for new modulators of this protein in a
context devoid of human ABC proteins.
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